The Impact of the Therapeutic Virtual Reality Headset on Patient Anxiety in the Waiting Room Before Flexible Bronchoscopy in Vigil
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: virtual reality device.
- Who it may be relevant to
- Registry conditions: Bronchial Fibroscopy. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- France
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
Bronchial fibroscopy is a frequently used procedure in the management of pneumology patients, and can be a source of anxiety, particularly while waiting for the examination. Investigator's professional experience has shown us that many patients are anxious in the waiting room before a flexible bronchoscopy in vigile. A great deal of research has been carried out into the use of virtual reality to reduce anxiety and pain during care but shortly before bronchoscopy. The innovative aspect is to target the patient's waiting time for the examination. Waiting is a highly anxiety-provoking time, and nurses play a vital role in supporting patients.
Interventions
- Device virtual reality device
20 minutes session with virtual reality device
Primary outcome measures
- Anxiety assessment [Time frame: Immediately after intervention]
Secondary outcome measures (1)
- Assessment of bronchoscopy realisation and sample collection [Time frame: Immediately after intervention]
Eligibility criteria
Inclusion criteria
- Adult patients with no age or gender restrictions, seen on an outpatient basis at Le Mans Hospital.
- In whom bronchial fibroscopy is indicated.
- Person affiliated with or benefiting from a social security .
- Free, informed and written consent signed by the participant and the investigator (no later than the day of inclusion and before any examination required by the research).
- Patient able and willing to answer questionnaires
Exclusion criteria
- Patient refusing to participate in research
- Patient who has already undergone bronchoscopy in vigil
- Patient premedicated for bronchial fibroscopy (anxiolytic, etc.)
- Patients with a history of epilepsy or psychiatric pathology
- Patient with vertigo
- Patient uncooperative, demented or unable to tolerate headgear.
- patient under guardianship or curatorship
- Patients suffering from blindness or deafness
- Patient with known significant intolerance to screens and/or virtual reality devices
- Pregnant, nursing or parturient women
- Unscheduled patients: emergencies, etc.
- Hospitalized patients
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Supportive care
Study locations
France · 1 center
- Centre Hospitalier Le Mans — Le Mans
Identifiers
NCT: NCT06799806 · CHM-2024/S15/04